Abstract
Many biomarkers have been identified to be new targeted drugs for lung cancer treatment. Their clinical outcomes are determined by their status mainly evaluated from primary cancer tissues. However, metastasis is the leading cause of death in cancer patients. It is unclear whether their status in primary cancers is similar to that in corresponding metastases. Therefore, we aimed to evaluate similarities or differences for the selected biomarker expression between primary lung cancers and matched metastases and to provide evidence for further using these targets in metastatic tumors from lung cancer. Eleven patients who had received resection of paired tissues of primary lung cancers and matched metastases were collected. The protein expression of VEGF, HIF-1α, Met, P53, TGF-β1, Cox-2 and TNF-α between paired tumors was detected by immunohistochemistry. The results showed that there was no statistical significance between primary cancers and matched metastases for the expressions of the selected biomarkers. The p values were more than 0.05. The major concordance of the selected biomarkers existed between paired primary and metastatic tumors. However, there were still minor differences. Differences in metastases compared with primary tumors were observed in respective two cases for VEGF, HIF-1α and Met, respective one case for TGF-β1, COX2 and TNFα and three cases for P53. In conclusion, there were major concordance and minor difference for each biomarker between primary lung tumors and corresponding metastases, which may have important implications for the understanding of current metastasis models and treatment of advanced lung cancers.
References
Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350(4):379–92.
Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367–80.
Sequist LV, Bell DW, Lynch TJ, et al. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol. 2007;25:587–95.
Girard N, Deshpande C, Azzoli CG, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. Chest. 2010;137:46–52.
Wang G, Dong W, Shen H, et al. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases. Eur J Cardiothorac Surg. 2011;39:1028–32.
Wu JM, Fackler MJ, Halushka MK, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008;14(7):1938–46.
Kurokawa T, Miyamoto M, Kato K, et al. Overexpression of hypoxia-inducible-factor 1α (HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer. 2003;89(6):1042–7.
Sakai K, Kaku T, Kamura T, et al. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer. Gynecol Oncol. 1999;72(3):360–6.
Loncaster JA, Cooper RA, Logue JP, et al. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer. 2000;83(5):620–5.
Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer. 1999 15;86(8):1455–62.
Han C, Zou H, Ma J, et al. Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis. Zhongguo Fei Ai Za Zhi. 2010;13:882–91.
Vignot S, Frampton GM, Soria JC, et al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol. 2013;31:2167–72.
Takahashi K, Kohno T, Matsumoto S, et al. Clonal and parallel evolution of primary lung cancers and their metastases revealed by molecular dissection of cancer cells. Clin Cancer Res. 2007;13(1):111–20.
Talmadge JE. Clonal selection of metastasis within the life history of a tumor. Cancer Res. 2007;67(24):11471–5.
Bar J, Herbst RS, Onn A. Targeted drug delivery strategies to treat lung metastasis. Expert Opin Drug Deliv. 2009;6(10):1003–16.
Acknowledgments
This work was supported by Provincial Science and Technology Development Planning of Shandong (2011GGH21819), Provincial Science and Technology Development Planning of Shandong (2012G0021836), and Provincial Natural Science Foundation of Shandong (ZR2011HM077).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dongwei Gao and Tiehong Zhang have equally contributed to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gao, D., Zhang, T., Li, S. et al. A comparison on expression of selected biomarkers between primary lung cancers and matched metastases. Med Oncol 30, 742 (2013). https://doi.org/10.1007/s12032-013-0742-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-013-0742-1